Newsletter

BioMedReports Can Fite Biopharma Ltd (ADR) NYSEMKT CANF) Slumps On Drug Trial Failure: Biotechnology Company Can Fite Bioph... http://t.co/uJyi3bOgmN
3hreplyretweetfavorite
BioMedReports Orexigen Therapeutics, Inc. (NASDAQ:OREX) stock surges as Mysimba gets European approval: Orexigen Therapeuti... http://t.co/kx3IQxiSKV
BioMedReports Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study; pSivida Completes Targeted Enrollme... http://t.co/SbqW0QaKPV